title: [Combined use of irradiation and DNA tumor vaccine to treat canine oral malignant melanoma: a pilot study].
abstract: Melanoma is the most common oral tumor in dogs, characterized by rapid growth, local invasion, and high metastatic rate. The goal of this study was to evaluate the combination of radiation therapy and DNA tumor vaccine. We hypothesized, that the concurrent use would not increase toxicity. Nine dogs with oral melanoma were treated with 4 fractions of 8 Gray at 7-day intervals. The vaccine was given 4 times every 14 days, beginning at the first radiation fraction. Local acute radiation toxicities were assessed according to the VRTOG toxicity scoring scheme over a time period of 7 weeks. In none of the evaluated dogs, mucositis, dermatitis and conjunctivitis exceeded grade 2. In 3 dogs mild fever, lethargy, and local swelling at the injection site were seen after vaccine application. In conclusion, the concurrent administration of radiation therapy and vaccine was well tolerated in all dogs.
authors: Animal Oncology and Imaging Center, Hünenberg. herzog@aoicenter.ch
authors: A
authors: A
authors: Herzog
authors: J
authors: J
authors: Buchholz
authors: K
authors: K
authors: Ruess-Melzer
authors: J
authors: J
authors: Lang
authors: B
authors: B
authors: Kaser-Hotz
mesh_terms: D000818:Animals; D019496:Cancer Vaccines / Q000627:therapeutic use*; D003131:Combined Modality Therapy / Q000662:veterinary; D004283:Dog Diseases / Q000532:radiotherapy / Q000628:therapy*; D004285:Dogs; D005260:Female; D008297:Male; D008545:Melanoma / Q000532:radiotherapy / Q000628:therapy / Q000662:veterinary*; D009062:Mouth Neoplasms / Q000532:radiotherapy / Q000628:therapy / Q000662:veterinary*; D010865:Pilot Projects; D019444:Vaccines, DNA / Q000627:therapeutic use*
chemical_list: D019496:Cancer Vaccines; D019444:Vaccines, DNA